Filing Details
- Accession Number:
- 0001209191-17-063697
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-12-05 07:43:03
- Reporting Period:
- 2017-12-01
- Accepted Time:
- 2017-12-05 07:43:03
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1008848 | Acorda Therapeutics Inc | ACOR | Biological Products, (No Disgnostic Substances) (2836) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1272353 | David Lawrence | 420 Saw Mill River Road Ardsley NY 10502 | Chief, Bus. Ops & Pao | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2017-12-01 | 3,993 | $20.51 | 4,693 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Sales pursuant to a 10b5-1 plan.
- The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $20.10 to $20.90 per share. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
Billionaire Hedge Funds
